journal article·2024-05Open access

Reprogramming of the LXRα Transcriptome Sustains Macrophage Secondary Inflammatory Responses

Juan Vladimir de la Rosa, Carlos Tabraue, Zhiqiang Huang, Marta C. Orizaola, Patricia Martin‐Rodríguez, Knut R. Steffensen, Juan Manuel Zapata, Lisardo Boscá, Peter Tontonoz, Susana Alemany, Eckardt Treuter, Antonio Castrillo

Advanced Science· Volume 11· Issue 20

Abstract

Abstract Macrophages regulate essential aspects of innate immunity against pathogens. In response to microbial components, macrophages activate primary and secondary inflammatory gene programs crucial for host defense. The liver X receptors (LXRα, LXRβ) are ligand‐dependent nuclear receptors that direct gene expression important for cholesterol metabolism and inflammation, but little is known about the individual roles of LXRα and LXRβ in antimicrobial responses. Here, the results demonstrate that induction of LXRα transcription by prolonged exposure to lipopolysaccharide (LPS) supports inflammatory gene expression in macrophages. LXRα transcription is induced by NF‐κB and type‐I interferon downstream of TLR4 activation. Moreover, LPS triggers a reprogramming of the LXRα cistrome that promotes cytokine and chemokine gene expression through direct LXRα binding to DNA consensus sequences within cis‐regulatory regions including enhancers. LXRα‐deficient macrophages present fewer binding of p65 NF‐κB and reduced histone H3K27 acetylation at enhancers of secondary inflammatory response genes. Mice lacking LXRα in the hematopoietic compartment show impaired responses to bacterial endotoxin in peritonitis models, exhibiting reduced neutrophil infiltration and decreased expansion and inflammatory activation of recruited F4/80 lo ‐MHC‐II hi peritoneal macrophages. Together, these results uncover a previously unrecognized function for LXRα‐dependent transcriptional cis‐activation of secondary inflammatory gene expression in macrophages and the host response to microbial ligands.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Cholesterol and Lipid Metabolism · interferon and immune responses · Immune Cell Function and Interaction

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Unidad de Biomedicina (Unidad Asociada al CSIC) Instituto Universitario de Investigaciones Biomédicas y Sanitarias (IUIBS) de la Universidad de Las Palmas de Gran Canaria Las Palmas 35016 Spain

Departamento de Morfología Universidad de Las Palmas de Gran Canaria Las Palmas 35016 Spain

Department of Biosciences and Nutrition Karolinska Institutet, NEO Huddinge 14183 Sweden

Center for Translational Medicine and Jiangsu Key Laboratory of Molecular Medicine Medical School Nanjing University Nanjing 210093 P. R. China

Department of Metabolic and Immune Diseases. Instituto de Investigaciones Biomédicas Sols‐Morreale Centro Mixto Consejo Superior de Investigaciones Científicas CSIC‐Universidad Autónoma de Madrid Madrid 28029 Spain

Division of Clinical Chemistry, Department of Laboratory Medicine Karolinska Institute Huddinge 14186 Sweden

Centro de Investigación Biomedica en Red sobre Enfermedades Cardiovasculares (CIBERCV) Madrid 28029 Spain

Department of Pathology and Laboratory Medicine University of California Los Angeles UCLA California 90095 USA

Funding

European Foundation for the Study of Diabetes · Novo Nordisk Fonden · Swedish e-Science Research Centre · Ministerio de Ciencia e Innovación

References (80)

Show source-provided references
1. 10.1146/annurev-immunol-061020-05373410.1146/annurev-immunol-061020-053734 ↗
2. 10.1038/nature2415410.1038/nature24154 ↗
3. 10.1146/annurev-physiol-021909-13584610.1146/annurev-physiol-021909-135846 ↗
4. 10.1016/j.immuni.2011.05.00610.1016/j.immuni.2011.05.006 ↗
5. 10.1016/j.molcel.2010.05.00410.1016/j.molcel.2010.05.004 ↗
6. 10.1016/j.immuni.2010.02.00810.1016/j.immuni.2010.02.008 ↗
7. 10.1016/j.ceb.2013.07.00610.1016/j.ceb.2013.07.006 ↗
8. 10.1016/S1074-7613(02)00390-410.1016/S1074-7613(02)00390-4 ↗
9. 10.1016/j.cell.2009.05.04710.1016/j.cell.2009.05.047 ↗
10. 10.1038/nature0583610.1038/nature05836 ↗
11. 10.1101/gad.257592.11410.1101/gad.257592.114 ↗
12. 10.1016/j.cell.2016.01.02010.1016/j.cell.2016.01.020 ↗
13. 10.1038/s41574-018-0037-x10.1038/s41574-018-0037-x ↗
14. 10.1038/383728a010.1038/383728a0 ↗
15. 10.1074/jbc.272.6.313710.1074/jbc.272.6.3137 ↗
16. 10.1074/jbc.M21307120010.1074/jbc.M213071200 ↗
17. 10.1038/nm82010.1038/nm820 ↗
18. 10.1016/j.molcel.2006.11.02210.1016/j.molcel.2006.11.022 ↗
19. 10.1101/gad.54511010.1101/gad.545110 ↗
20. 10.4049/jimmunol.180.5.330510.4049/jimmunol.180.5.3305 ↗
21. 10.1016/j.coph.2020.05.00110.1016/j.coph.2020.05.001 ↗
22. 10.1016/j.cell.2004.09.03210.1016/j.cell.2004.09.032 ↗
23. 10.1172/JCI3528810.1172/JCI35288 ↗
24. 10.1089/sur.2010.06610.1089/sur.2010.066 ↗
25. 10.1128/MCB.00376-1810.1128/MCB.00376-18 ↗
26. 10.1210/me.2004-052910.1210/me.2004-0529 ↗
27. 10.1073/pnas.040774910110.1073/pnas.0407749101 ↗
28. 10.1128/MCB.00534-1710.1128/MCB.00534-17 ↗
29. 10.1128/MCB.00364-1910.1128/MCB.00364-19 ↗
30. 10.1371/journal.pcbi.100002110.1371/journal.pcbi.1000021 ↗
31. 10.1194/jlr.M900107-JLR20010.1194/jlr.M900107-JLR200 ↗
32. 10.1016/j.cmet.2006.11.01210.1016/j.cmet.2006.11.012 ↗
33. 10.1126/science.111230410.1126/science.1112304 ↗
34. 10.7554/eLife.1302410.7554/eLife.13024 ↗
35. 10.1016/j.molcel.2012.10.01310.1016/j.molcel.2012.10.013 ↗
36. 10.1042/BJ2010170110.1042/BJ20101701 ↗
37. 10.1073/pnas.111419410810.1073/pnas.1114194108 ↗
38. 10.1074/jbc.M30582020010.1074/jbc.M305820200 ↗
39. 10.1126/science.108726210.1126/science.1087262 ↗
40. 10.1074/jbc.M60378120010.1074/jbc.M603781200 ↗
41. 10.1126/science.125479010.1126/science.1254790 ↗
42. 10.1016/j.cell.2012.12.01810.1016/j.cell.2012.12.018 ↗
43. 10.1186/1471-2164-13-5010.1186/1471-2164-13-50 ↗
44. 10.1073/pnas.101607110710.1073/pnas.1016071107 ↗
45. 10.1016/j.molcel.2020.12.04010.1016/j.molcel.2020.12.040 ↗
46. 10.1182/blood-2013-01-47820610.1182/blood-2013-01-478206 ↗
47. 10.1073/pnas.091500010710.1073/pnas.0915000107 ↗
48. 10.1038/ni.262210.1038/ni.2622 ↗
49. 10.1016/j.immuni.2019.11.00110.1016/j.immuni.2019.11.001 ↗
50. 10.1016/S0140-6736(63)92808-310.1016/S0140-6736(63)92808-3 ↗
51. 10.1371/journal.pgen.100240110.1371/journal.pgen.1002401 ↗
52. 10.1038/ni.330610.1038/ni.3306 ↗
53. 10.1146/annurev-immunol-031210-10130310.1146/annurev-immunol-031210-101303 ↗
54. 10.1016/S1097-2765(03)00384-810.1016/S1097-2765(03)00384-8 ↗
55. 10.1002/1873-3468.1270210.1002/1873-3468.12702 ↗
56. 10.1038/nrd428010.1038/nrd4280 ↗
57. 10.1073/pnas.070109610410.1073/pnas.0701096104 ↗
58. 10.7554/eLife.0800910.7554/eLife.08009 ↗
59. 10.1161/CIRCRESAHA.112.26904310.1161/CIRCRESAHA.112.269043 ↗
60. 10.1194/jlr.M00648610.1194/jlr.M006486 ↗
61. 10.3389/fendo.2021.63592310.3389/fendo.2021.635923 ↗
62. 10.1016/j.cmet.2013.10.00210.1016/j.cmet.2013.10.002 ↗
63. 10.1016/j.immuni.2009.06.01810.1016/j.immuni.2009.06.018 ↗
64. 10.1074/jbc.M60523720010.1074/jbc.M605237200 ↗
65. 10.1016/j.celrep.2017.05.09310.1016/j.celrep.2017.05.093 ↗
66. 10.1161/CIRCULATIONAHA.122.05906210.1161/CIRCULATIONAHA.122.059062 ↗
67. 10.1073/pnas.140427111110.1073/pnas.1404271111 ↗
68. 10.1016/j.immuni.2012.11.00410.1016/j.immuni.2012.11.004 ↗
69. 10.1038/ni.268110.1038/ni.2681 ↗
70. 10.1016/j.cell.2015.11.04510.1016/j.cell.2015.11.045 ↗
71. 10.1016/j.cmet.2020.05.00310.1016/j.cmet.2020.05.003 ↗
72. 10.1073/pnas.033638510010.1073/pnas.0336385100 ↗
73. 10.1074/jbc.M110.18291510.1074/jbc.M110.182915 ↗
74. 10.1016/j.immuni.2012.11.00510.1016/j.immuni.2012.11.005 ↗
75. 10.1038/nri375510.1038/nri3755 ↗
76. 10.1016/j.cmet.2016.11.00910.1016/j.cmet.2016.11.009 ↗
77. 10.1016/j.immuni.2019.09.00210.1016/j.immuni.2019.09.002 ↗
78. 10.1016/j.immuni.2019.08.01710.1016/j.immuni.2019.08.017 ↗
79. Rosa J. V. · Methods Mol. Biol. · 2018
80. 10.1038/s41467-019-09234-610.1038/s41467-019-09234-6 ↗